The relationship between the transforming growth factor β 1 T29C gene polymorphism and left ventricular geometry and function in hypertensive subjects

International Journal of Hypertension

Volumn 2010, Issue , 2010, Pages

  Scaglione, Rosario ^a   Argano, Christiano ^b   Duro, Giovanni ^c   Di Chiara, Tiziana ^a   Nuzzo, Domenico ^c   Colomba, Daniela ^a   Fiore, Maria Cristina ^c   Corrao, Salvatore ^a   Licata, Giuseppe ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b Dipartimento di Medicina Interna Fondazione San Raffaele GGiglio   (Italy)

^c CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROCOLLAGEN; PROCOLLAGEN TYPE 3; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD FLOW VELOCITY; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; DISEASE SEVERITY; DNA POLYMORPHISM; DOPPLER ECHOGRAPHY; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE; GENETIC ASSOCIATION; GENOTYPE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART POSTERIOR WALL THICKNESS; HEART RELATIVE WALL THICKNESS; HEART SIZE; HEART VENTRICLE SIZE; HUMAN; HYPERTENSION; INTERVENTRICULAR SEPTUM DIAMETER; ISOVOLUMETRIC RELAXATION TIME; LEFT VENTRICULAR TELEDIASTOLIC INTERNAL DIAMETER; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; TGFBETA1 GENE; TRANSMITRAL FLOW VELOCITY;

EID: 84859000817     PISSN: 20900384     EISSN: 20900392     Source Type: Journal    
DOI: 10.4061/2010/647147     Document Type: Article

References (29)

1. Chobanian A. V., Bakris G. L., Black H. R., The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. Journal of the American Medical Association 2003 289 19 2560 2572 2-s2.0-0030041630 10.1001/jama.289.19.2560 (Pubitemid 37430158)
2. Weber K. T., Fibrosis and hypertensive heart disease. Current Opinion in Cardiology 2000 15 4 264 272 10.1097/00001573-200007000-00010 2-s2.0-0033916114 (Pubitemid 30496722)
3. Laviades C., Varo N., Díez J., Transforming growth factor β in hypertensives with cardiorenal damage. Hypertension 2000 36 4 517 522 2-s2.0-0033779229
4. Parrinello G., Licata A., Colomba D., Left ventricular filling abnormalities and obesity-associated hypertension: relationship with overproduction of circulating transforming growth factor β 1. Journal of Human Hypertension 2005 19 7 543 550 10.1038/sj.jhh.1001864 2-s2.0-21744449977 (Pubitemid 40946039)
5. Scaglione R., Argano C., Parrinello G., Relationship between transforming growth factor β 1 and progression of hypertensive renal disease. Journal of Human Hypertension 2002 16 9 641 645 10.1038/sj.jhh.1001465 2-s2.0-0036746633
6. Kuwahara F., Kai H., Tokuda K., Transforming growth factor- β function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats. Circulation 2002 106 1 130 135 2-s2.0-0034677796 10.1161/01.CIR.0000020689.12472.E0 (Pubitemid 34747453)
7. Zeisberg E. M., Tarnavski O., Zeisberg M., Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nature Medicine 2007 13 8 952 961 10.1038/nm1613 2-s2.0-34547676391 (Pubitemid 47222040)
8. Scaglione R., Argano C., Corrao S., Di Chiara T., Licata A., Licata G., Transforming growth factor β 1 and additional renoprotective effect of combination ACE inhibitor and angiotensin II receptor blocker in hypertensive subjects with minor renal abnormalities: a 24-week randomized controlled trial. Journal of Hypertension 2005 23 3 657 664 2-s2.0-18844412138 (Pubitemid 40684726)
9. Scaglione R., Argano C., Di Chiara T., Effect of dual blockade of renin-angiotensin system on TGF β 1 and left ventricular structure and function in hypertensive patients. Journal of Human Hypertension 2007 21 4 307 315 10.1038/sj.jhh.1002161 2-s2.0-33947378232 (Pubitemid 46443592)
10. Ellmers L. J., leigh.ellmers@chmeds.ac.nz Scott N. J. A., Medicherla S., Transforming growth factor- β blockade down-regulates the renin-angiotensin system and modifies cardiac remodeling after myocardial infarction. Endocrinology 2008 149 11 5828 5834 2-s2.0-0037630699 10.1210/en.2008-0165
11. Lijnen P. J., paul.lijnen@med.kuleuven.ac.be Petrov V. V., Fagard R. H., Association between transforming growth factor- β and hypertension. American Journal of Hypertension 2003 16 7 604 611 2-s2.0-0033812921 10.1016/S0895-7061(03)00847-1 (Pubitemid 36829713)
12. Cambien F., Ricard S., Troesch A., Polymorphisms of the transforming growth factor- β 1 gene in relation to myocardial infarction and blood pressure: the etude cas-temoin de linfarctus du myocarde (ECTIM) study. Hypertension 1996 28 5 881 887 2-s2.0-10344243008 (Pubitemid 26365534)
13. Awad M. R., El-Gamel A., Hasleton P., Genotypic variation in the transforming growth factor- β 1 gene: association with transforming growth factor- β 1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation 1998 66 8 1014 1020 10.1097/00007890- 199810270-00009 2-s2.0-0032573136 (Pubitemid 28513380)
14. Yokota M., Ichihara S., Lin T.-L., Nakashima N., Yamada Y., Association of a T29 → C polymorphism of the transforming growth factor- β 1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation 2000 101 24 2783 2787 2-s2.0-0034690805 (Pubitemid 30396007)
15. Li B., Khanna A., Sharma V., Singh T., Suthanthiran M., August P., TGF- β 1 DNA polymorphisms, protein levels, and blood pressure. Hypertension 1999 33 1 271 275 2-s2.0-0032609711 (Pubitemid 29065671)
16. Koch W., Hoppmann P., Mueller J. C., Schomig A., Kastrati A., Association of transforming growth factor- β 1 gene polymorphisms with myocardial infarction in patients with angiographically proven coronary heart disease. Arteriosclerosis, Thrombosis, and Vascular Biology 2006 26 5 1114 1119 10.1161/01.ATV.0000217747.66517.11 2-s2.0-33646456211 (Pubitemid 43732120)
17. Khanna A., Li B., Stenzel K. H., Suthanthiran M., Regulation of new DNA synthesis in mammalian cells by cyclosporine: demonstration of a transforming growth factor β -dependent mechanism of inhibition of cell growth. Transplantation 1994 57 4 577 582 (Pubitemid 24075806)
18. Risteli J., Niemi S., Trivedi P., Maentausta O., Mowat A. P., Risteli L., Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen. Clinical Chemistry 1988 34 4 715 718
19. de Simone G., Daniels S. R., Devereux R. B., Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. Journal of the American College of Cardiology 1992 20 5 1251 1260
20. Licata G., Scaglione R., Corrao S., Heredity and obesity-associated hypertension: impact of hormonal characteristics and left ventricular mass. Journal of Hypertension 1995 13 6 611 618 2-s2.0-0029125626 10.1097/00004872- 199506000-00006
21. Hosmer D. W., Lemeshow S., Applied Logistic Regression 2000 New York, NY, USA John Wiley & Sons
22. Xu H. Y., Hu X. W., Wang L. F., Wang N. F., Xu J., Association between transforming growth factor β 1 and left ventricular hypertrophy in essential hypertensive subjects. Molecular and Cellular Biochemistry 2010 335 1-2 13 17
23. Villar A. V., Llano M., Cobo M., Gender differences of echocardiographic and gene expression patterns in human pressure overload left ventricular hypertrophy. Journal of Molecular and Cellular Cardiology 2009 46 4 526 535 10.1016/j.yjmcc.2008.12.024 2-s2.0-61449201755
24. Scaglione R., Argano C., Di Chiara T., Central obesity and hypertensive renal disease: association between higher levels of BMI, circulating transforming growth factor β 1 and urinary albumin excretion. Blood Pressure 2003 12 5-6 269 276 10.1080/08037050310016484 2-s2.0-1642464900 (Pubitemid 38128473)
25. Derhaschnig U., Shehata M., Herkner H., Increased levels of transforming growth factor- β 1 in essential hypertension. American Journal of Hypertension 2002 15 3 207 211 10.1016/S0895-7061(01)02327-5 2-s2.0-0036126317 (Pubitemid 34226183)
26. Porreca E., Di Febbo C., Mincione G., Increased transforming growth factor- β production and gene expression by peripheral blood monocytes of hypertensive patients. Hypertension 1997 30 1 134 139 2-s2.0-0030789689 (Pubitemid 27306359)
27. Fukuda N., Hu W.-Y., Kubo A., Abnormal regulation of transforming growth factor- β receptors on vascular smooth muscle cells from spontaneously hypertensive rats by angiotensin II. Hypertension 1998 31 2 672 677 2-s2.0-0031934184 (Pubitemid 28086954)
28. Bray P., Agrotis A., Bobik A., Alex.Bobik@alice.baker.edu.au Transforming growth factor- β and receptor tyrosine kinase-activating growth factors negatively regulate collagen genes in smooth muscle of hypertensive rats. Hypertension 1998 31 4 986 994 2-s2.0-0028953768 (Pubitemid 28185578)
29. Soylemezoglu O., Wild G., Dalley A. J., Urinary and serum type III collagen: markers of renal fibrosis. Nephrology Dialysis Transplantation 1997 12 9 1883 1889 10.1093/ndt/12.9.1883 2-s2.0-0030774021 (Pubitemid 27379461)